Losem, C., Koenigsmann, M., & Rudolph, C. (2017). Biosimilar Retacrit(®) (epoetin zeta) in the treatment of chemotherapy-induced symptomatic anemia in hematology and oncology in Germany (ORHEO) – non-interventional study. Onco Targets Ther.
Citação norma ChicagoLosem, Christoph, Michael Koenigsmann, and Christine Rudolph. "Biosimilar Retacrit(®) (epoetin Zeta) in the Treatment of Chemotherapy-induced Symptomatic Anemia in Hematology and Oncology in Germany (ORHEO) – Non-interventional Study." Onco Targets Ther 2017.
Citação norma MLALosem, Christoph, Michael Koenigsmann, and Christine Rudolph. "Biosimilar Retacrit(®) (epoetin Zeta) in the Treatment of Chemotherapy-induced Symptomatic Anemia in Hematology and Oncology in Germany (ORHEO) – Non-interventional Study." Onco Targets Ther 2017.